UTCBS presents its work at the international congress of the “controlled release society” in Bologna.
The UTCBS team has shown the interest of nanoparticles both for the imaging of ROS in vivo and the promotion of antioxydant therapeutic activity.
Caroline Roques showed that nanoemulsions produced by HPH can stabilise EPR probes and that the probe remain stable after in vivo injection. This work is supported by an innovation funding.
Her PhD, MD Nasir Arafath has shown novel cerium oxide nanoparticles and their property as antioxydant in the context of stroke. He will soon defend his PhD on that topic. Khair Alhareth addressed the interest of DOE together with machine learning in a preliminary study on liposomes. These methods are currently being applicated for the programs on LNP for the delivery of mRNA in the UTCBS lab. Finally, the work on nanocrystals led by Pr Yohann Corvis has been presented by Dr Nathalie Mignet showing their interest both as antiinflammatory and anticancer nanomedicine.
